Endocrinology
News from the FDA/CDC
FDA approves first over-the-counter birth control pill
The product, OPill, is expected to be available early in 2024.
Latest News
Treating obesity: Will new drugs end the crisis?
The drugs offer new hope to millions with obesity complications. But to truly turn the tide on our 42% obesity rate, much more work remains to be...
Conference Coverage
Thirty-three percent of type 1 diabetes patients insulin free with stem cells
Engraftment of Vertex Pharmaceutical’s VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Commentary
Does ‘skeletal age’ describe fracture impact on mortality?
Mortality risk may be related to patients not fully understanding the consequence of a fragility fracture.
Conference Coverage
Scripts surge for desiccated thyroid extract to treat hypothyroidism
Among first-time thyroid hormone prescriptions, those for DTE rose from 5.4% in 2010 to 10.2% in 2020.
Conference Coverage
A ‘one-stop shop’: New guidance on hormones and aging
Part of what we need to do is [provide] the evidence that we have, which includes evidence of when not to prescribe as well as [when] to prescribe...
Conference Coverage
BMI ‘vastly underestimates’ true obesity
“We’re at the start of the end of BMI.”
Conference Coverage
Anabolic-steroid withdrawal regimens show promise in men
“There is a vacuum of medical advice on what to do” when men stop taking steroids.
Conference Coverage
PCOS associated with shorter lifespan
“I think we need to acknowledge that this is a health burden and not just a reproductive problem.”
Conference Coverage
Big trial reassures on heart safety of testosterone in men
“The community of physicians who prescribe testosterone to men was waiting with bated breath” for the TRAVERSE results.